Self-reported adherence to oral cancer therapy: Relationships with symptom distress, depression, and personal characteristics

Patient Preference and Adherence

Volumn 9, Issue , 2015, Pages 1587-1592

  Berry, Donna L ^a,b   Blonquist, Traci M ^a   Hong, Fangxin ^a,c   Halpenny, Barbara ^a   Partridge, Ann H ^a,b  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Logistic regression; Patient centered technology; Recursive partitioning; Self management

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGED; AGING; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER THERAPY; COLORECTAL CANCER; DEPRESSION; DISTRESS SYNDROME; FEMALE; HORMONAL THERAPY; HUMAN; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MALE; MEDICATION COMPLIANCE; PATIENT HEALTH QUESTIONNAIRE 9; PATIENT PREFERENCE; PROSTATE CANCER; RANDOMIZED CONTROLLED TRIAL (TOPIC); SARCOMA; SELF CARE; SELF REPORT; SEX DIFFERENCE; SOCIAL STATUS; SYMPTOM DISTRESS SCALE; TREATMENT REFUSAL; VERY ELDERLY;

EID: 84946830196     PISSN: None     EISSN: 1177889X     Source Type: Journal    
DOI: 10.2147/PPA.S91534     Document Type: Article

References (26)

1. Hershman DL, Shao T, Kushi LH, et al. Early discontinuation and non-adherence to adjuvant hormonal therapy are associated with increased mortality in women with breast cancer. Breast Cancer Res Treat. 2011;126(2):529-537.
2. Neuss MN, Polovich M, McNiff K, et al. 2013 updated American Society of Clinical Oncology/Oncology Nursing Society chemotherapy administration safety standards including standards for the safe administration and management of oral chemotherapy. Oncol Nurs Forum. 2013;40(3):225-233.
3. Levine AM, Richardson JL, Marks G, et al. Compliance with oral drug therapy in patients with hematologic malignancy. J Clin Oncol. 1987;5(9):1469-1476.
4. Johnson LA. Factors influencing oral adherence: qualitative metasummary and triangulation with quantitative evidence. Clin J Oncol Nurs. 2015;19(3):6-30.
5. Mathes T, Pieper D, Antoine SL, Eikermann M. Adherence influencing factors in patients taking oral anticancer agents: a systematic review. Cancer Epidemiol. 2014;38(3):214-226.
6. Bassan F, Peter F, Houbre B, et al. Adherence to oral antineoplastic agents by cancer patients: definition and literature review. Eur J Cancer Care. 2014;23(1):22-35.
7. Kavookjian J, Wittayanukorn S. Interventions for adherence with oral chemotherapy in hematological malignancies: a systematic review. Res Social Adm Pharm. 2015;11(3):303-314.
8. Mathes T, Antoine SL, Pieper D, Eikermann M. Adherence enhancing interventions for oral anticancer agents: a systematic review. Cancer Treat Rev. 2014;40(1):102-108.
9. Spoelstra SL, Sansoucie H. Putting evidence into practice: evidence-based interventions for oral agents for cancer. Clin J Oncol Nurs. 2015;19(3):60-72.
10. Berry DL, Hong F, Halpenny B, et al. Electronic self-report assessment for cancer and self-care support: results of a multicenter randomized trial. J Clin Oncol. 2014;32(3):199-205.
11. McCorkle R, Cooley M, Shea J. A User's Manual for the Symptom Distress Scale. New Haven: Yale University; 2000.
12. Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16(9):606-613.
13. Fann JR, Berry DL, Wolpin S, et al. Depression screening using the Patient Health Questionnaire-9 administered on a touch screen computer. Psychooncology. 2009;18(1):14-22.
14. Morisky DE, Ang A, Krousel-Wood M, Ward HJ. Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hypertens. 2008;10(5):348-354.
15. Sommers RM, Miller K, Berry DL. Feasibility pilot on medication adherence and knowledge in ambulatory patients with gastrointestinal cancer. Oncol Nurs Forum. 2012;39(4):E373-E379.
16. James G, Witten D, Hastie T, Tibshiran R. An introduction to statistical learning: with applications in R. In: Casella G, Fienberg S, Olkin I, editors. Springer Texts in Statistics. New York: Springer Science+Business Media LLC; 2014. Available from: http://www-bcf.usc.edu/~gareth/ISL/ISLR%20Fourth%20Printing.pdf
17. Therneau TM, Atkinson EJ. An introduction to recursive partitioning using the RPART routines; 2015. Available from: http://cran.r-project.org/web/packages/rpart/vignettes/longintro.pdf. Accessed June 29, 2015.
18. Lebovits AH, Strain JJ, Schleifer SJ, Tanaka JS, Bhardwaj S, Messe MR. Patient noncompliance with self-administered chemotherapy. Cancer. 1990;65(1):17-22.
19. Siefert M, Blonquist T, Berry DL, Hong F. Symptom-related emergency department visits and hospital admissions during ambulatory cancer treatment. J Comm Supp Oncol. 2015;13:188-194.
20. Hershman DL, Kushi LH, Shao T, et al. Early discontinuation and nonadherence to adjuvant hormonal therapy in a cohort of 8, 769 early-stage breast cancer patients. J Clin Oncol. 2010;28(27):4120-4128.
21. Noens L, van Lierde MA, De Bock R, et al. Prevalence, determinants, and outcomes of nonadherence to imatinib therapy in patients with chronic myeloid leukemia: the ADAGIO study. Blood. 2009;113(22):5401-5411.
22. Artherholt SB, Hong F, Berry DL, Fann JR. Risk factors for depression in patients undergoing hematopoietic cell transplantation. Biol Blood Marrow Transplant. 2014;20(7):946-950.
23. Vance DE, Cody SL, Yoo-Jeong M, Jones GL, Nicholson WC. The role of employment on neurocognitive reserve in adults with HIV: a review of the literature. J Assoc Nurses AIDS Care. 2015;26(4):316-329.
24. Berry DL, Hong F, Halpenny B. Psychosocial outcomes of the electronic self-report assessment for cancer-II randomized trial. Paper presented at: American Society of Clinical Oncology Annual Meeting; June 1, 2015; Chicago.
25. Kav S, Schulmeister L, Nirenberg A, Barber L, Johnson J, Rittenberg C. Development of the MASCC teaching tool for patients receiving oral agents for cancer. Support Care Cancer. 2010;18(5):583-590.
26. Boucher J, Lucca J, Hooper K, Pedulla L, Berry D. A Structured nursing intervention to address oral chemotherapy adherence in patients with non-small cell lung cancer. Oncol Nurs Forum. 2015;42(4):383-389.